Antibody-drug conjugates (ADCs) may be a big breakthrough in gynecologic cancer treatment (I).

Competing Interests: Conflicts of interest Drs. Peng-Hui Wang, Chia-Hao Liu, and Szu-Ting Yang, editorial board members at Taiwanese Journal of Obstetrics and Gynecology, had no role in the peer review process of or decision to publish this article. The authors declare that they have no conflicts of interest related to the subject matter or materials discussed in this article.